Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells

Mark J. Smyth(Heidelberg Repatriation Hospital), Kevin Thia(Heidelberg Repatriation Hospital), Shayna E.A. Street(Heidelberg Repatriation Hospital), Erika Cretney(Heidelberg Repatriation Hospital), Joseph A. Trapani(Heidelberg Repatriation Hospital), Masaru Taniguchi(Chiba University), Tetsu Kawano(Chiba University), Sonja B. Pelikan(Monash University), Nadine Y. Crowe(Monash University), Dale I. Godfrey(Monash University)
The Journal of Experimental Medicine
February 21, 2000
Cited by 803Open Access
Full Text

Abstract

Natural tumor surveillance capabilities of the host were investigated in six different mouse tumor models where endogenous interleukin (IL)-12 does or does not dictate the efficiency of the innate immune response. Gene-targeted and lymphocyte subset-depleted mice were used to establish the relative importance of natural killer (NK) and NK1.1(+) T (NKT) cells in protection from tumor initiation and metastasis. In the models examined, CD3(-) NK cells were responsible for tumor rejection and protection from metastasis in models where control of major histocompatibility complex class I-deficient tumors was independent of IL-12. A protective role for NKT cells was only observed when tumor rejection required endogenous IL-12 activity. In particular, T cell receptor Jalpha281 gene-targeted mice confirmed a critical function for NKT cells in protection from spontaneous tumors initiated by the chemical carcinogen, methylcholanthrene. This is the first description of an antitumor function for NKT cells in the absence of exogenously administered potent stimulators such as IL-12 or alpha-galactosylceramide.


Related Papers

No related papers found

Powered by citation graph analysis